Skip to main content
ABINGDON HEALTH PLC logo

ABINGDON HEALTH PLC — Investor Relations & Filings

Ticker · ABDX ISIN · GB00BLF79J41 LEI · 213800XFI4WV3FBILO20 IL Manufacturing
Open in API
Filings indexed 237 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country GB United Kingdom
Listing IL ABDX

About ABINGDON HEALTH PLC

https://www.abingdonhealth.com/

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Recent filings

Filing Released Lang Actions
Launch of LVOne Stroke Test by UpFront Diagnostics
Regulatory Filings Classification · 92% confidence The document is a press release disseminated via RNS detailing a product launch (UK launch of LVOne Stroke Triage Test) and company partnership activities. It does not contain financial statements, voting results, management changes, dividends, or other structured report content. It is not announcing the publication of a formal report (Menu vs Meal rule). This fits the fallback category for general regulatory announcements through RNS.
2026-05-11 English
Holding(s) in Company
Regulatory Filings
2026-05-07 English
Update on Partnership with 4TEEN4 Pharmaceuticals
Regulatory Filings
2026-05-06 English
Admission to trading on OTCQB in the US
Regulatory Filings Classification · 85% confidence The document is an RNS announcement titled “Admission to trading on OTCQB Venture Market in the US,” which announces a trading/listing event rather than providing a detailed financial report or shareholder meeting materials. It is not an AGM presentation, annual or interim report, earnings release, or financing update. It does not involve share issuance details or insider transactions. Therefore it falls under the general regulatory announcement category. Filing type: Regulatory Filings (RNS).
2026-04-21 English
Trading to commence on the OTCQB in the US
Regulatory Filings Classification · 85% confidence The document is clearly an RNS announcement by Abingdon Health plc (London Stock Exchange Regulatory News Service), with an RNS header and RNS Number. It is a corporate notice about the commencement of trading on the OTCQB market in the US, not an earnings release, management discussion, or formal financial report, nor a share issue or split. It is thus a general regulatory announcement that does not fit other more specific categories. Accordingly, it should be classified under the fallback category Regulatory Filings (RNS).
2026-04-14 English
£4.8m contracts awarded
Regulatory Filings Classification · 85% confidence The document is a London Stock Exchange RNS announcement (RNS Number: 5354Y) disclosing the award of new contracts worth £4.8m to Abingdon Health plc. It is not an earnings release, dividend notice, board change, or financial report – it’s a general business update published via a Regulatory Information Service. This fits the “Regulatory Filings” fallback category (Code: RNS).
2026-03-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.